Medicare Enrolled
Dr. Philippe Saxe, M.D.
Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saxe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saxe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saxe
Dr. Philippe Saxe is a rheumatology specialist in Delray Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Saxe performed 108,787 Medicare services across 9,659 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saxe received a total of $18,044 from 54 pharmaceutical and/or device companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saxe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in FL
$18,044 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 51332 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗108,787
Medicare services
Top 23% in FL for rheumatology
9,659
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,726 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 32,505 | $4 | $12 |
| Tocilizumab injection (Actemra) | 19,240 | $5 | $7 |
| Denosumab injection (Prolia/Xgeva) | 18,180 | $18 | $25 |
| Romosozumab injection (Evenity) for osteoporosis | 14,175 | $8 | $12 |
| Steroid injection (triamcinolone) | 3,807 | $1 | $10 |
| Infliximab infusion (Remicade) | 3,410 | $27 | $100 |
| Office visit, established patient (30-39 min) | 1,401 | $96 | $150 |
| Blood draw (venipuncture) | 886 | $8 | $9 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 792 | $13 | $35 |
| Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 780 | $12 | $25 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 727 | $59 | $100 |
| Calcium level, total | 726 | $5 | $8 |
| Urea nitrogen level to assess kidney function, quantitative | 697 | $4 | $12 |
| Blood creatinine level | 696 | $5 | $12 |
| Complete blood count (CBC) with differential | 693 | $8 | $31 |
| Phosphatase (enzyme) level, alkaline | 668 | $5 | $15 |
| Liver enzyme (sgot), level | 667 | $5 | $15 |
| Liver enzyme (sgpt), level | 667 | $5 | $15 |
| Bilirubin level, total | 665 | $5 | $12 |
| Albumin (protein) level | 659 | $5 | $8 |
| C-reactive protein test (inflammation marker) | 513 | $5 | $12 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 509 | $4 | $12 |
| Uric acid level test | 484 | $4 | $8 |
| Blood potassium level | 476 | $5 | $8 |
| Blood sodium level | 474 | $5 | $12 |
| Methotrexate sodium, 5 mg | 391 | $0 | $5 |
| Joint injection, major joint | 307 | $47 | $135 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 294 | $18 | $30 |
| Vitamin D level test | 276 | $29 | $55 |
| Injection into tendon at attachment to bone or muscle | 176 | $25 | $90 |
| Administration of chemotherapy into vein, 1 hour or less | 169 | $108 | $250 |
| Bone density scan (DEXA) | 157 | $39 | $125 |
| Analysis of substance using immunoassay technique, multiple step method | 156 | $11 | $20 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 152 | $178 | $272 |
| Aspiration and/or injection of fluid from small joint | 135 | $35 | $93 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 115 | $82 | $236 |
| Blood glucose (sugar) level | 113 | $4 | $12 |
| Office visit, established patient (20-29 min) | 106 | $69 | $100 |
| Screening test for autoimmune disorder | 98 | $12 | $25 |
| X-ray of hand, minimum of 3 views | 96 | $30 | $50 |
| Injection, zoledronic acid, 1 mg | 95 | $7 | $80 |
| Injection into tendon or ligament | 94 | $41 | $91 |
| Cardiolipin antibody (tissue antibody) measurement | 90 | $25 | $40 |
| Measurement of antibody for rheumatoid arthritis assessment | 89 | $13 | $25 |
| Office visit, established patient, complex (40-54 min) | 86 | $139 | $200 |
| New patient office visit (45-59 min) | 83 | $119 | $225 |
| Rheumatoid factor level | 78 | $6 | $25 |
| Injection of trigger points, 3 or more muscles | 71 | $26 | $85 |
| Administration of chemotherapy into vein, each additional hour | 67 | $23 | $75 |
| Knee X-ray, 3 views | 66 | $33 | $55 |
| Injection of trigger points, 1-2 muscles | 59 | $22 | $80 |
| Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | 51 | $61 | $204 |
| Shoulder X-ray, 2+ views | 50 | $29 | $50 |
| Hip X-ray, 2-3 views | 47 | $37 | $60 |
| Aspiration and/or injection of fluid from medium joint | 46 | $37 | $96 |
| Measurement of dna antibody, native or double stranded | 42 | $13 | $30 |
| Measurement of dna antibody, single stranded | 42 | $12 | $20 |
| X-ray of lower and sacral spine, 2-3 views | 39 | $32 | $65 |
| Measurement of complement (immune system proteins), antigen, | 39 | $12 | $30 |
| Measurement of complement function (immune system proteins) | 39 | $12 | $30 |
| Foot X-ray, 3+ views | 30 | $27 | $50 |
| Thyroid stimulating hormone (TSH) test | 29 | $16 | $40 |
| X-ray of both hips, 3-4 views | 24 | $39 | $75 |
| Creatine kinase (cardiac enzyme) level, total | 24 | $6 | $12 |
| X-ray of upper spine, 2-3 views | 21 | $32 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 20 | $51 | $115 |
| X-ray of knee, 1-2 views | 19 | $25 | $45 |
| Injection of anesthetic agent and/or steroid into rib nerve | 16 | $69 | $230 |
| Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | 16 | $28 | $340 |
| New patient office visit, complex (60-74 min) | 16 | $173 | $285 |
| X-ray of middle spine, 3 views | 14 | $33 | $65 |
| Urinalysis, manual | 13 | $3 | $6 |
| X-ray of elbow, 2 views | 12 | $22 | $45 |
| X-ray of wrist, minimum of 3 views | 11 | $31 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $68 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
84.4% medium
12.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,044
Total received (2018-2024)
Avg $2,578/year across 7 years
Top 26% in FL for rheumatology
54
Companies
837
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,302 (84.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,334 (12.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$408 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,527
2023
$1,825
2022
$2,153
2021
$2,075
2020
$1,530
2019
$2,755
2018
$3,179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$3,200
Amgen Inc.
$2,289
Novartis Pharmaceuticals Corporation
$1,326
UCB, Inc.
$1,071
E.R. Squibb & Sons, L.L.C.
$1,004
AbbVie Inc.
$920
PFIZER INC.
$884
GlaxoSmithKline, LLC.
$813
Boehringer Ingelheim Pharmaceuticals, Inc.
$616
Mallinckrodt Hospital Products Inc.
$569
ABBVIE INC.
$563
Genentech USA, Inc.
$519
Radius Health, Inc.
$506
Lilly USA, LLC
$398
AbbVie, Inc.
$368
AstraZeneca Pharmaceuticals LP
$338
Mallinckrodt LLC
$314
GENZYME CORPORATION
$312
SANOFI-AVENTIS U.S. LLC
$278
Sobi, Inc
$197
Celgene Corporation
$191
Mallinckrodt Enterprises LLC
$148
Horizon Therapeutics plc
$144
SOBI, INC
$122
DePuy Synthes Sales Inc.
$106
Aurinia Pharma U.S., Inc.
$67
Flexion Therapeutics, Inc.
$65
Actelion Pharmaceuticals US, Inc.
$62
Merck Sharp & Dohme Corporation
$58
Fresenius Kabi USA, LLC
$51
Biocon Biologics Inc
$49
Alvogen Inc
$44
Ultragenyx Pharmaceutical Inc.
$44
Kyowa Kirin, Inc.
$42
ANI Pharmaceuticals, Inc.
$34
West-Ward Pharmaceuticals
$33
Horizon Pharma plc
$30
Hikma Pharmaceuticals USA
$26
Alexion Pharmaceuticals, Inc.
$22
TerSera Therapeutics LLC
$22
Cumberland Pharmaceuticals, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
SCILEX PHARMACEUTICALS INC.
$17
Organon LLC
$17
Zyla Life Sciences
$14
MEDEXUS PHARMA, INC.
$14
MEDAC PHARMA, INC.
$14
Collegium Pharmaceutical, Inc.
$14
Gilead Sciences, Inc.
$14
Eyevance Pharmaceuticals LLC
$13
Avion Pharmaceuticals
$12
Ironwood Pharmaceuticals, Inc
$12
Organon Llc
$11
Bioventus LLC
$11
Top 3 companies account for 37.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · Enbrel · FLUMIST QUADRIVALENT · FORTEO · GELSYN 3 · HADLIMA · HUMIRA · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SYNVISC-ONE · Seglentis · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ · Xtampza ER · ZORVOLEX · ZTLido · Zerviate · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Saxe is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Saxe experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Saxe performed 32,505 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saxe receive payments from pharmaceutical companies?
Yes. Dr. Saxe received a total of $18,044 from 54 companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saxe's costs compare to other rheumatologists in Delray Beach?
Dr. Saxe's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saxe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Delray Beach
Browse rheumatologists in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology